CleanCore Solutions (ZONE) 10-Q 10 Jun 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Mar. 31, 2024	Jun. 07, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Information [Line Items]
Entity Registrant Name	CleanCore Solutions, Inc.
Entity Central Index Key	0001956741
Entity File Number	001-42033
Entity Tax Identification Number	88-4042082
Entity Incorporation, State or Country Code	NV
Current Fiscal Year End Date	--06-30
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	5920 S 118th Circle
Entity Address, City or Town	Omaha
Entity Address, Country	NE
Entity Address, Postal Zip Code	68137
Entity Phone Fax Numbers [Line Items]
City Area Code	(877)
Local Phone Number	860-3030
Entity Listings [Line Items]
Title of 12(b) Security	Class B Common Stock, par value $0.0001 per share
Trading Symbol	ZONE
Security Exchange Name	NYSEAMER
Entity Common Stock, Shares Outstanding		7,955,919
Former Address [Member]
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	13714 A Street
Entity Address, City or Town	Omaha
Entity Address, Country	NE
Entity Address, Postal Zip Code	68144

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Current assets:
Cash	$ 56,082	$ 393,194
Accounts receivable, net	296,054	233,560
Inventory, net	775,685	672,116
Deferred offering costs	773,749	302,755
Prepaid expenses and other current assets	40,890	135,666
Total current assets	1,942,460	1,737,291
Property and equipment, net	2,946	1,197
Right of use assets	556,107	466,661
Intangibles	1,525,422	1,640,919
Goodwill	2,237,910	2,237,910
Other assets	9,440	9,440
Total assets	6,274,285	6,093,418
Current liabilities:
Accounts payable and accrued expenses	1,601,224	644,627
Lease liability - current	128,749	87,985
Note payable	3,225,000	2,994,750
Total current liabilities	5,226,289	3,948,664
Lease liability – non current	452,564	398,540
Total liabilities	5,678,853	4,347,204
Commitments and contingencies (Note 12)
Stockholders’ Equity
Series Seed Preferred Stock, $0.0001 par value, 4,000,000 shares authorized; 1,000,000 and 4,000,000 shares issued and outstanding as of March 31, 2024 and June 30, 2023, respectively	100	400
Additional paid-in capital	6,920,756	6,768,775
Accumulated deficit	(6,325,970)	(5,023,207)
Total stockholders’ equity	595,432	1,746,214
Total liabilities and stockholders’ equity	6,274,285	6,093,418
Related Party
Current liabilities:
Due to related parties	271,316	221,302
Class A Common Stock
Stockholders’ Equity
Common stock value	15	66
Class B Common Stock
Stockholders’ Equity
Common stock value	$ 531	$ 180

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2024	Jun. 30, 2023
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, shares issued	1,000,000	4,000,000
Preferred stock, shares outstanding	1,000,000	4,000,000
Class A Common Stock
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	150,000	660,000
Common stock, shares outstanding	150,000	660,000
Class B Common Stock
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	5,305,940	1,795,940
Common stock, shares outstanding	5,305,940	1,795,940

Condensed Statement of Operatio

Condensed Statement of Operations (Unaudited) - USD ($)	3 Months Ended		4 Months Ended	5 Months Ended	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Oct. 16, 2022	Mar. 31, 2023	Mar. 31, 2024
Successor
Revenue	$ 313,920	$ 621,406		$ 1,470,175	$ 898,010
Cost of Sales	173,184	368,528		999,556	457,495
Gross profit	140,736	252,878		470,619	440,515
Operating expenses:
General and administrative	559,398	502,446		4,853,405	1,466,594
Advertising expense	17,737	2,210		12,814	43,191
Depreciation expense	178				388
Loss from operations	(436,577)	(251,778)		(4,395,600)	(1,069,658)
Interest expense	84,093	71,979		113,493	233,105
Net loss	$ (520,670)	$ (323,757)		$ (4,509,093)	$ (1,302,763)
Successor | Class A and Class B Stock
Operating expenses:
Net loss per share of Class A and Class B stock, basic (in Dollars per share)	$ (0.11)	$ (0.13)		$ (2.03)	$ (0.34)
Successor | Class A Common Stock
Operating expenses:
Weighted average shares used in computing net loss per share, basic (in Shares)	231,319	1,000,000		1,000,000	341,788
Successor | Class B Common Stock
Operating expenses:
Weighted average shares used in computing net loss per share, basic (in Shares)	4,405,940	1,438,699		1,221,028	3,451,743
Predecessor
Revenue			$ 502,990
Cost of Sales			351,740
Gross profit			151,250
Operating expenses:
General and administrative			334,812
Advertising expense			4,621
Depreciation expense			6,143
Loss from operations			(194,326)
Interest expense			125,738
Net loss			$ (320,064)

Condensed Statement of Operat_2

Condensed Statement of Operations (Unaudited) (Parentheticals) - Successor - $ / shares	3 Months Ended		5 Months Ended	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2023	Mar. 31, 2024
Class A and Class B stock
Net loss per share of Class A and Class B stock, diluted (in Dollars per share)	$ (0.11)	$ (0.13)	$ (2.03)	$ (0.34)
Class A Common Stock
Weighted average shares used in computing net loss per share, diluted	231,319	1,000,000	1,000,000	341,788
Class B Common Stock
Weighted average shares used in computing net loss per share, diluted	4,405,940	1,438,699	1,221,028	3,451,743

Condensed Statement of Stockhol

Condensed Statement of Stockholders’ Equity (Unaudited) - USD ($)	Preferred Stock Predecessor Series Seed	Preferred Stock Successor Series Seed	Preferred Stock Series Seed	Common Stock Predecessor Class A	Common Stock Predecessor Class B	Common Stock Successor Class A	Common Stock Successor Class B	Common Stock Class A	Common Stock Class B	Additional Paid in Capital Predecessor	Additional Paid in Capital Successor	Additional Paid in Capital	Accumulated Deficit Predecessor	Accumulated Deficit Successor	Accumulated Deficit	Members Capital Amount Predecessor	Members Capital Amount Successor	Predecessor	Successor	Total
Balance at Jun. 30, 2022													$ (8,224,933)			$ 2,215,916		$ (6,009,017)
Balance (in Shares) at Jun. 30, 2022
Imputed interest																125,728		125,728
Net loss for the period													(320,064)					(320,064)
Balance at Oct. 16, 2022													(8,544,997)			2,341,644		(6,203,353)
Balance (in Shares) at Oct. 16, 2022
Issuance of series seed preferred stock		$ 400									999,600								1,000,000
Issuance of series seed preferred stock (in Shares)		4,000,000
Issuance of class A common stock						$ 100													100
Issuance of class A common stock (in Shares)						1,000,000
Issuance of class B common stock							$ 66				1,152,156								1,152,222
Issuance of class B common stock (in Shares)							660,921
Issuance of class B common stock upon exercise of warrants							$ 78				497,700								497,778
Issuance of class B common stock upon exercise of warrants (in Shares)							777,778
Warrants issued to consultants for services											857,889								857,889
Stock based compensation – officers											3,082,000								3,082,000
Net loss for the period														(4,185,336)					(4,185,336)
Balance at Dec. 31, 2022		$ 400				$ 100	$ 144				6,589,345			(4,185,336)					2,404,653
Balance (in Shares) at Dec. 31, 2022		4,000,000				1,000,000	1,438,699
Balance at Oct. 16, 2022													$ (8,544,997)			$ 2,341,644		$ (6,203,353)
Balance (in Shares) at Oct. 16, 2022
Net loss for the period																			(4,509,093)
Balance at Mar. 31, 2023		$ 400				$ 100	$ 144				6,646,898			(4,509,093)					2,138,449
Balance (in Shares) at Mar. 31, 2023		4,000,000				1,000,000	1,438,699
Balance at Dec. 31, 2022		$ 400				$ 100	$ 144				6,589,345			(4,185,336)					2,404,653
Balance (in Shares) at Dec. 31, 2022		4,000,000				1,000,000	1,438,699
Stock based compensation – 2022 Equity Incentive Plan											57,553								57,553
Net loss for the period														(323,757)					(323,757)
Balance at Mar. 31, 2023		$ 400				$ 100	$ 144				$ 6,646,898			$ (4,509,093)					2,138,449
Balance (in Shares) at Mar. 31, 2023		4,000,000				1,000,000	1,438,699
Balance at Jun. 30, 2023			$ 400					$ 66	$ 180			$ 6,768,775			$ (5,023,207)					$ 1,746,214
Balance (in Shares) at Jun. 30, 2023			4,000,000					660,000	1,795,940
Conversion of class A common stock into class B common stock								$ (131)	$ 131
Conversion of class A common stock into class B common stock (in Shares)								(1,310,000)	1,310,000
Conversion of series seed preferred stock into class A common stock			$ (100)					$ 100
Conversion of series seed preferred stock into class A common stock (in Shares)			(1,000,000)					1,000,000
Stock based compensation – 2022 Equity Incentive Plan												63,960								63,960
Net loss for the period															(437,294)					(437,294)
Balance at Sep. 30, 2023			$ 300					$ 35	$ 311			6,832,735			(5,460,501)					1,372,880
Balance (in Shares) at Sep. 30, 2023			3,000,000					350,000	3,105,940
Balance at Jun. 30, 2023			$ 400					$ 66	$ 180			6,768,775			(5,023,207)					1,746,214
Balance (in Shares) at Jun. 30, 2023			4,000,000					660,000	1,795,940
Net loss for the period																			(1,302,763)	(1,302,763)
Balance at Mar. 31, 2024			$ 100					$ 15	$ 531			6,920,756			(6,325,970)					595,432
Balance (in Shares) at Mar. 31, 2024			1,000,000					150,000	5,305,940
Balance at Sep. 30, 2023			$ 300					$ 35	$ 311			6,832,735			(5,460,501)					1,372,880
Balance (in Shares) at Sep. 30, 2023			3,000,000					350,000	3,105,940
Stock based compensation – 2022 Equity Incentive Plan												44,012								44,012
Net loss for the period															(344,799)					(344,799)
Balance at Dec. 31, 2023			$ 300					$ 35	$ 311			6,876,747			(5,805,300)					1,072,093
Balance (in Shares) at Dec. 31, 2023			3,000,000					350,000	3,105,940
Conversion of class A common stock into class B common stock								$ (220)	$ 220
Conversion of class A common stock into class B common stock (in Shares)								(2,200,000)	2,200,000
Conversion of series seed preferred stock into class A common stock			$ (200)					$ 200
Conversion of series seed preferred stock into class A common stock (in Shares)			(2,000,000)					2,000,000
Stock based compensation – 2022 Equity Incentive Plan												44,009								44,009
Net loss for the period															(520,670)				$ (520,670)	(520,670)
Balance at Mar. 31, 2024			$ 100					$ 15	$ 531			$ 6,920,756			$ (6,325,970)					$ 595,432
Balance (in Shares) at Mar. 31, 2024			1,000,000					150,000	5,305,940

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	4 Months Ended	5 Months Ended	9 Months Ended
	Oct. 16, 2022	Mar. 31, 2023	Mar. 31, 2024
Successor
Cash flows from operating activities
Net loss		$ (4,509,093)	$ (1,302,763)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		72,082	115,885
Accretion of note payable discount		12,750	5,250
Non cash interest expense		100,117	223,783
Stock based compensation		3,997,442	151,981
Non cash lease expense		19,373	5,342
Imputed interest
Provision for bad debt and write-off of on uncollectable accounts		8,641	29,923
Changes in operating assets and liabilities:
Accounts receivable		(455,599)	(92,417)
Inventory		332,355	(103,569)
Due from related parties, net
Prepaid expenses		(16,377)	94,776
Deferred revenue
Accounts payable and accrued liabilities		269,242	386,279
Net cash used in operating activities		(169,067)	(485,530)
Cash flows from investing activities
Cash used in acquisition		(2,000,000)
Purchase of property and equipment			(2,138)
Net cash used in investing activities		(2,000,000)	(2,138)
Cash flows from financing activities
Payments for deferred offering costs		(150,683)	(124,458)
Proceeds from issuance of series seed preferred stock		1,000,000
Proceeds from issuance of class A common stock		100
Proceeds from issuance of class B common stock		1,650,000
Proceeds from issuance of convertible debt notes			225,000
Repayments of long term debt
Proceeds from issuance of loans from related parties		234,566	50,014
Repayments of loans due to related parties
Net cash provided by (used in) financing activities		2,733,983	150,556
Net increase (decrease) in cash		564,916	(337,112)
Cash at beginning of period			393,194
Cash at the end of period		564,916	56,082
Supplementary cash flow disclosure
Interest paid		13,376	9,322
Unpaid deferred offering costs		45,546	$ 346,536
Predecessor
Cash flows from operating activities
Net loss	(320,064)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,420
Accretion of note payable discount
Non cash interest expense
Stock based compensation
Non cash lease expense
Imputed interest	125,728
Provision for bad debt and write-off of on uncollectable accounts	9,772
Changes in operating assets and liabilities:
Accounts receivable	101,423
Inventory	(157,596)
Due from related parties, net	4,686
Prepaid expenses	4,747
Deferred revenue	63,701
Accounts payable and accrued liabilities	43,932
Net cash used in operating activities	(117,251)
Cash flows from investing activities
Cash used in acquisition
Purchase of property and equipment	(7,882)
Net cash used in investing activities	(7,882)
Cash flows from financing activities
Payments for deferred offering costs
Proceeds from issuance of series seed preferred stock
Proceeds from issuance of class A common stock
Proceeds from issuance of class B common stock
Proceeds from issuance of convertible debt notes
Repayments of long term debt	(1,278)
Proceeds from issuance of loans from related parties	164,917
Repayments of loans due to related parties	(288,861)
Net cash provided by (used in) financing activities	(125,222)
Net increase (decrease) in cash	(250,355)
Cash at beginning of period	263,506	$ 13,151
Cash at the end of period	13,151
Supplementary cash flow disclosure
Interest paid	10
Unpaid deferred offering costs

Organization and Business

Organization and Business	9 Months Ended
	Mar. 31, 2024
Organization and Business [Abstract]
Organization and Business	1. Organization and Business CC Acquisition Corp. was incorporated in the State of Nevada on August 23, 2022 for the sole purpose of acquiring substantially all of the assets of CleanCore Solutions, LLC, TetraClean Systems, LLC, and Food Safety Technologies, LLC, pursuant to an asset purchase agreement entered into by CC Acquisition Corp. with these three entities and their owners on October 17, 2022. On November 21, 2022, CC Acquisition Corp. changed its name to CleanCore Solutions, Inc. (“the Company” or “Successor”). Since the Company acquired substantially all of the assets of each of CleanCore Solutions, LLC, TetraClean Systems, LLC, and Food Safety Technologies, LLC, the business of these three entities is now operated by the Company, with no subsidiaries. The combined results of CleanCore Solutions, LLC, TetraClean Systems, LLC and Food Safety Technologies, LLC presented in these financial statements represent the predecessor entity of the Company (“Predecessor”). The Company specializes in the development and manufacturing of cleaning products that produce pure aqueous ozone products for professional, industrial, or home use. The Company has a patented nanobubble technology using aqueous ozone that it believes is highly effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas. The Company offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. Its products are used in many types of environments including retail establishments, distribution centers, factories, warehouses, restaurants, schools and universities, airports, healthcare, food service, and commercial buildings such as offices, malls, and stores. The headquarters, principal address and records of the Company are located at 5920 South 118th Circle, Suite 2, Omaha, Nebraska. Liquidity and Going Concern The Company has incurred losses and negative cash flows from operations. From acquisition through March 31, 2024, the Company has financed its operations primarily through investor funding. As of March 31, 2024, the Company had cash of $56,082, a net loss for the nine-month period ended of $1,302,763 and cash used in operating activities of $485,530. In accordance with Accounting Standards Codification (ASC) Topic 205-40, Presentation of Financial Statements - Going Concern As noted above, the Company was formed in August 2022 and completed the acquisition in October 2022. Since the acquisition, the Company has invested in further developing the Company’s products, hiring key personnel, and engaging third party experts such as accountants and underwriters in connection with the Company’s initial public offering described below. On April 25, 2024, the Company entered into an underwriting agreement with Boustead Securities, LLC, as the representative of the several underwriters named on Schedule 1 thereto, relating to the Company’s initial public offering of class B common stock. Under the underwriting agreement, the Company agreed to sell 1,250,000 shares of class B common stock to the underwriters, at a purchase price per share of $3.72 (the offering price to the public of $4.00 per share minus the underwriters’ 7% discount), and also agreed to grant to the underwriters a 45-day option to purchase up to 187,500 additional shares of class B common stock, at a purchase price of $3.72. On April 30, 2024, the closing of the initial public offering was completed. The Company sold 1,250,000 shares of class B common stock for total gross proceeds of $5,000,000. After deducting the underwriting commission and expenses, the Company received net proceeds of approximately $4,239,500. Despite the initial public offering, management believes that currently available resources will not be sufficient to fund the Company’s planned expenditures over the next 12 months. These factors, individually and collectively indicate that a material uncertainty exists that raises substantial doubt about the Company’s ability to continue as a going concern for 12 months from the date of issuance of these unaudited condensed financial statements. The Company will be dependent upon the raising of additional capital through equity and/or debt financing in order to implement its business plan and generate sufficient revenue in excess of costs. If the Company raises additional capital through the issuance of equity securities or securities convertible into equity, stockholders will experience dilution, and such securities may have rights, preferences or privileges senior to those of the holders of common stock. If the Company raises additional funds by issuing debt, the Company may be subject to limitations on its operations, through debt covenants or other restrictions. There is no assurance that the Company will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect on the Company’s financial condition. These unaudited condensed financial statements do not include any adjustments to the amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The accompanying unaudited condensed financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying unaudited interim financial statements as of and for the three and nine-month periods ended March 31, 2024 and 2023 have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The interim financial statements are condensed and should be read in conjunction with the Company’s latest annual audited 2023 financial statements. The results of operations for interim periods are not necessarily indicative of results to be expected for the fiscal year ending June 30, 2024 or for any other future annual or interim period. The results of the Predecessor represent the combined financial statements of the accounts of CleanCore Solutions, LLC, TetraClean Systems, LLC and Food Safety Technologies, LLC. These combined financial statements include the accompanying combined statements of operations for the period ended July 1 to October 16, 2022, combined statement of members’ equity as of June 30, 2022 and October 16, 2022, and combined statement of cash flows for the period July 1, 2022 to October 16, 2022. All intercompany balances and transactions among the combined entities have been eliminated. In the opinion of predecessor management, all adjustments considered necessary for a fair presentation have been included. Use of Estimates The preparation of the Company’s and Predecessor’s financial statements require management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure in the Company’s combined financial statements and accompanying notes. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management’s estimates. Significant estimates and assumptions made by the Company are allowance for bad debt, useful lives of fixed assets, warranty liabilities, and allowance for inventory obsolescence. Risks and Uncertainties The Company is subject to a number of risks similar to other early-stage companies including, but not limited to, profitability, the need for additional financing to achieve its business strategy, ability to obtain regulatory approval, significant competition, and dependence on key individuals. Accounts Receivable Accounts receivable is comprised of trade accounts receivables from the Company’s customers. Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company established an allowance for bad debt of accounts receivables based on a percentage assigned to aged days outstanding categories. The Predecessor established the allowance for bad debt based on various factors including credit profiles of the Company’s customers, historical payments, outstanding balances and current economic trends, and performed this analysis periodically. The Company recorded an allowance for doubtful accounts of $20,585 and $4,419 as of March 31, 2024 and June 30, 2023, respectively. Inventory Inventory consists of parts, work in progress and finished goods. The Company and its Predecessor value parts and finished goods at the lower of the actual costs or net realizable value. The Company and its Predecessor value work in progress at cost. The Company and Predecessor periodically review inventory for obsolete and potentially impaired items. As of March 31, 2024 and June 30, 2023, the Company had an allowance for inventory obsolescence of $19,235 and $14,940, respectively. Leases The Company accounts for leases in accordance with Accounting Standards Codification (ASC) Topic 842 (Topic 842), Leases Lease payments include fixed and in-substance fixed payments, variable payments based on an index or rate, reasonably certain purchase options, termination penalties, and probable amounts the lessee will owe under a residual value guarantee. Variable lease payments are recognized as lease expenses as incurred, and generally relate to variable payments made based on the level of services provided by the landlords of our leases. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term within general and administrative expenses in the statement of operations. The Company uses its estimated incremental borrowing rate, which is derived from information available at the lease commencement date, in determining the present value of lease payments because the Company does not have the information necessary to determine the rate implicit in the lease. The Company’s lease term includes any option to extend the lease when it is reasonably certain to be exercised based on consideration of all relevant factors. Leases with an initial term of 12 months or less are not recorded on the balance sheets and the Company recognizes lease expense for these leases on a straight-line basis over the lease term. Business Combinations Business combinations are accounted for using the acquisition method. The fair value of total purchase consideration is allocated to the fair values of identifiable tangible and intangible assets acquired and liabilities assumed, with the remaining amount being classified as goodwill. All assets, liabilities and contingent liabilities acquired or assumed in a business combination are recorded at their fair values at the date of acquisition. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates, and selection of comparable companies. Estimates of fair value are based on assumptions believed to be reasonable, but are inherently uncertain and unpredictable and, as a result, actual results may differ from those estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. At the conclusion of the measurement period, any subsequent adjustments are reflected in the statements of operations. Transaction costs associated with business combinations are expensed as incurred and are included in general and administrative expenses in the Company’s statements of operations. Intangible Assets Intangible assets primarily consist of existing technology, customer relationships, and trademarks obtained as a result of the acquisition on October 17, 2022. Intangible assets with definite lives are amortized based on their pattern of economic benefit over their estimated useful lives and reviewed periodically for impairment. The Company’s trademarks are deemed to have an indefinite life. The estimated useful life of the acquired technology is 15 years while the estimated useful life of the customer relationships is 5 years. Impairment of Goodwill The Company evaluates goodwill for impairment annually, as of June 30, or more frequently when indicators of impairment exist. The Company considers qualitative factors including market conditions, legal factors, operating performance indicators, and competition, among others, to determine whether it is more likely than not that the fair value of the reporting unit is less than it’s carrying amount, including goodwill. If the Company concludes that it is more likely than not that the fair value of the reporting unit is less than it’s carrying amount, the Company performs a quantitative impairment test. In performing the quantitative impairment test, the Company compares the fair value of its reporting unit to the carrying amount including the goodwill of the reporting unit. If the carrying value, including goodwill, exceeds the reporting unit’s fair value, the Company will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company performed its first evaluation of goodwill on October 1, 2023. Based on the analysis, the Company did not recognize an impairment loss during the period ended March 31, 2024. Subsequent evaluations will be performed annually on June 30, per the Company’s policy. Impairment of Long-Lived Assets Long-lived assets consist primarily of property and equipment and intangible assets. Long-lived assets are tested for impairment when events and circumstances indicate the assets might be impaired by first comparing the estimated future undiscounted cash flows of the asset or asset group to the carrying value. If the carrying value exceeds the estimated future undiscounted cash flows, an impairment loss is recognized based on the amount that the carrying value exceeds the fair value of the asset or asset group. The Company did not recognize impairment losses during the periods ended March 31, 2024 and 2023. Deferred Offering Costs In accordance with ASC 340-10-S99-1 and SEC Accounting Bulletin Topic 5A, specific incremental costs incurred by the Company directly attributable to a proposed offering of securities have been deferred and will be charged against the gross proceeds of the offering. These offering costs include fees paid to underwriters, attorney, accountants as well as printers and other third parties directly related to the offering. Costs such as management salaries or other general administrative expenses that are not incremental to the offering are not included in the deferred costs. As of March 31, 2024 and June 30, 2023, the Company had $773,749 and $302,755, respectively, of deferred offering costs. Patent Costs Costs related to filing and pursuing patent applications are expensed as incurred, as recoverability of such expenditures is uncertain. These costs are included in general and administrative expenses. Advertising Costs The Company reports as expense the cost of advertising and promoting its services as incurred. Such amounts are totaled $17,737 and $2,210 for the three-month periods ended March 31, 2024 and 2023, respectively, and $43,191 (successor), $12,814 (successor) and $4,621 (predecessor), for a total of $17,435, for the nine month periods ended March 31, 2024 and 2023, respectively. Stock-based Compensation Compensation expense is recognized for all share-based payments to employees and non-employees, including stock options and warrants, in the statements of operation based on the fair value of the awards that are granted. The Company’s stock price at the date of grant was estimated using an acceptable valuation technique such as the probability-weighted expected return model. The fair value of stock options is estimated at the date of grant using the Black-Scholes option-pricing model. Generally, measured compensation cost, net of actual forfeitures, is recognized on a straight-line basis over the vesting period of the related share-based compensation award. The Company accounts for forfeitures of stock-based awards as they occur. Revenue Recognition The Company generates revenues from sales of its products and recognizes revenue as control of its products is transferred to its customers, which is generally at the time of shipment based on the contractual terms with the Company’s customers. The Company provides customer programs and incentive offerings, including growth incentives and volume-based incentives. These customer programs and incentives are considered variable consideration. The Company includes in revenue variable consideration only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the variable consideration is resolved. This determination is made based upon known customer program and incentive offerings at the time of sale, and expected sales volume forecasts as it relates to the Company’s volume-based incentives. This determination is updated every reporting period. For the periods ended March 31, 2024 and 2023, customer growth and volume-based incentives were minimal. Certain product sales include a 2-year manufacturer’s warranty that provides the customer with assurance that the product performs as intended. Such warranties are assurance-type warranties and are accounted for as contingencies under ASC 460-10. Refer to Note 7 for warranty reserve. Net Loss per Share of Common Stock Basic net loss per class A and class B common share is calculated by dividing the net loss distributed to class A and class B, respectively, by the weighted-average number of common shares of each respective class outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, stock options, warrants, and convertible debt are considered to be potentially dilutive securities. As of March 31, 2024 and 2023, there were potential common stock equivalents excluded from the diluted loss per share calculations as their effect is anti-dilutive New Accounting Pronouncements No recent accounting pronouncement or changes in accounting pronouncements have been issued or adopted that are of material significance, or have potential material significance, to the Company’s financial statements since those discussed in the Company’s fiscal year 2023 audited financial statements.

Disaggregated Revenue

Disaggregated Revenue	9 Months Ended
	Mar. 31, 2024
Disaggregated Revenue [Abstract]
Disaggregated Revenue	3. Disaggregated Revenue The following table disaggregates revenue by product category for the following periods ended: Three Months Ended 2024 2023 Janitorial and Sanitation $ 258,819 $ 583,805 Ice System 6,549 9,601 Commercial and Residential Laundry 6,991 3,004 Other 41,561 24,996 Total revenue $ 313,920 $ 621,406 Nine Months Ended Nine March 31, (Successor) October 17, July 1, Janitorial and Sanitation $ 722,206 $ 1,430,570 $ 369,089 Ice System 10,133 16,059 16,744 Commercial and Residential Laundry 9,060 3,004 6,444 Other 156,611 20,542 110,713 Total revenue $ 898,010 $ 1,470,175 $ 502,990 The “Other” category of revenue consists primarily of sales of parts, accessories, shipping and handling, and equipment rental income.

Accounts Receivable, Net

Accounts Receivable, Net	9 Months Ended
	Mar. 31, 2024
Accounts Receivable, Net [Abstract]
Accounts Receivable, net	4. Accounts Receivable, net Accounts receivable, net consists of the following at: March 31, June 30, Trade accounts receivable $ 316,639 $ 237,979 Allowance for doubtful accounts (20,585 ) (4,419 ) Total accounts receivable, net $ 296,054 $ 233,560

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Mar. 31, 2024
Fair Value Measurements [Abstract]
Fair Value Measurements	5. Fair Value Measurements ASC Topic 820, Fair Value Measurement ASC 820 identifies fair value as the exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a three-tier fair value hierarchy that distinguishes between the following: Level 1 – Observable inputs such as quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs, other than quoted prices in active markets, that are observable for the asset or liability, either directly or indirectly. Level 3 – Unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. The Company’s financial assets are subject to fair value measurements on a recurring basis. The Company’s remaining carrying amounts reported in the consolidated balance sheets of these financial assets are a reasonable estimate of fair value due to their short-term nature.

Inventory

Inventory	9 Months Ended
	Mar. 31, 2024
Inventory [Abstract]
Inventory	6. Inventory Inventory consists of the following at: March 31, June 30, Parts $ 525,093 $ 551,264 Finished goods 269,827 135,792 Inventory reserve (19,235 ) (14,940 ) Total inventory, net $ 775,685 $ 672,116 The Company values inventory at the balance sheet date using the weighted average method. The Company adjusted the inventory reserve to $19,235 for the period ended March 31, 2024, from $14,940 for the year ended June 30, 2023.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	9 Months Ended
	Mar. 31, 2024
Accounts Payable and Accrued Expenses [Abstract]
Accounts Payable and Accrued Expenses	7. Accounts Payable and Accrued Expenses Accounts payable and accrued expenses consist of the following at: March 31, June 30, Accounts payable $ 722,734 $ 266,511 Accrued interest 376,467 152,684 Accrued payroll and related expenses 313,910 68,026 Warranty reserve 112,559 156,333 Other accrued expenses 75,554 1,073 Total accounts payable and other accrued expenses $ 1,601,224 $ 644,627

Debt

Debt	9 Months Ended
	Mar. 31, 2024
Debt [Abstract]
Debt	8. Debt In connection with the acquisition of the Predecessor on October 17, 2022, the Company issued a promissory note in the principal amount of $3,000,000 to the seller, Burlington Capital, LLC (“Burlington”), which bears interest at 7% per annum and matures on October 17, 2023. On September 13, 2023, the parties signed an extension agreement, pursuant to which the interest rate was increased to 10% per annum and the maturity date was extended to the earlier of (a) the closing of a firm commitment initial public offering and concurrent listing on a national securities exchange or (b) December 17, 2023. On December 17, 2023, the parties signed a second extension agreement, pursuant to which the maturity date was extended to the earlier of (a) the closing of a firm commitment initial public offering and concurrent listing on a national securities exchange or (b) April 4, 2024. As of March 31, 2024, the Company recorded accrued interest related to the note in the amount of $355,726. On January 30, 2024, the Company issued three 10% original issue discount convertible promissory notes to three separate accredited investors in the principal amounts of $27,778, $111,111, and $111,111. The purchase prices of the notes were $25,000, $100,000 and $100, , respectively. These notes accrue with simple interest on the outstanding principal amount at the rate of 12% per annum and the interest shall commence on the date of issuance and continue to accrue until paid in full or until the note is converted. The principal amounts and all accrued and unpaid interest automatically convert into class B common stock upon the closing of the Company’s initial public offering. The notes contain customary beneficial ownership limitations. Unless earlier converted into class B common stock, all unpaid interest and principal is due and payable on December 31, 2024, which date may be extended at the election of the Company by up to two additional 90-day periods.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	9. Related Party Transactions The following due to related party balances were outstanding at: March 31, June 30, Due to founder – credit card $ 62,416 $ 12,402 Due to founders 208,900 208,900 Total due to related parties $ 271,316 $ 221,302 As of March 31, 2024, the Company had a short term amount due to Clayton Adams, one of its founders, in the amount of $62,416 for operational expenses paid by a credit card in the founder’s name. The Company has a verbal agreement with Mr. Adams to pay the credit card charges directly to the issuing financial institution as they become due and is current on these payments. On October 4, 2022, the Company issued a promissory note to each of Matthew Atkinson, the Company’s Chief Executive Officer, and Clayton Adams, the Company’s President at such time, in the principal amount of $104,450 each, for a total of $208,900. These notes bear interest at a rate of 5% per annum beginning on the 30th day after issuance and are due on the 60th day following written demand from the holder. The Company has recorded this as a short-term note payable on the balance sheet, due to the demand terms of the agreement, and recorded related accrued interest of $15,567 as of March 31, 2024. As of March 31, 2024, the holders have not provided written demand to the Company. On March 26, 2024, the Company entered into a loan agreement with Clayton Adams, a significant stockholder, pursuant to which the Company issued a revolving credit note to Mr. Adams in the principal amount of up to $500,000. Pursuant to the loan agreement and note, Mr. Adams agreed to provide advances to the Company upon request during the period commencing on the effective date of the registration statement of which this prospectus forms a part and continuing until the second anniversary of such date, which is referred to as the maturity date. This note accrues simple interest on the outstanding principal amount at the rate of 8% per annum, with all principal and interest due on the maturity date; provided that upon an event of default (as defined in the note), such rate shall increase to 13%. The Company may prepay the note at any time without penalty or premium. The note is unsecured and contains customary events of default for a loan of this type. As of March 31, 2024, no advances have been made and the principal amount of this note is $0.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Mar. 31, 2024
Stockholders’ Equity [Abstract]
Stockholders' Equity	10. Stockholders’ Equity The Company’s authorized capital stock currently consists of 350,000,000 shares, consisting of (i) 300,000,000 shares of common stock, par value $0.0001 per share, of which 50,000,000 shares are designated class A common stock and 250,000,000 shares are designated as class B common stock; and (ii) 50,000,000 shares of “blank check” preferred stock, par value $0.0001 per share, of which 4,000,000 are designated as series seed preferred stock. Series Seed Preferred Stock Below is a summary of the terms of the series seed preferred stock. Ranking Liquidation Rights Dividends pari passu Voting Rights Conversion Rights On September 16, 2022, the Company issued an aggregate of 2,000,000 shares of series seed preferred stock at a purchase price of $0.25 per share. On September 30, 2022, the Company issued 2,000,000 shares of series seed preferred stock at a purchase price of $0.25 per share. On July 16, 2023, 1,000,000 shares of series seed preferred stock were converted into 1,000,000 shares of class A common stock. On February 5, 2024, 750,000 shares of series seed preferred stock were converted into 750,000 shares of class A common stock. On February 7, 2024, 1,250,000 shares of series seed preferred stock were converted into 1,250,000 shares of class A common stock. As of March 31, 2024, 1,000,000 shares of series seed preferred stock were issued and outstanding. Common Stock The Company has two classes of authorized common stock — class A common stock and class B common stock. The rights of the holders of the class A common stock and class B common stock are identical, except with respect to voting and conversion. Each share of class A common stock is entitled to ten votes per share and is convertible into one share of class B common stock. Each share of class B common stock is entitled to one vote per share. As of March 31, 2024, all of the outstanding class A common stock was held by one of the Company’s founders On August 26, 2022, the Company issued an aggregate of 1,000,000 shares of class A common stock at a purchase price of $0.0001 per share. On October 14, 2022, the Company issued an aggregate of 603,450 shares of class B common stock at a purchase price of $1.74 per share. On November 29, 2022, the Company issued 57,471 shares of class B common stock at a purchase price of $1.74 per share. On November 29, 2022, the Company issued 777,778 shares of class B common stock upon the exercise of a warrant for an aggregate exercise price of $500,000. On April 1, 2023, the Company issued 17,241 shares of class B common stock to a professional firm in exchange for services at $1.74 per share. Accordingly, stock compensation expense in the amount of $29,999 was recorded by the Company. On June 1, 2023, an aggregate of 340,000 shares of class A common stock were converted into an aggregate of 340,000 shares of class B common stock. On July 16, 2023, the Company issued 1,000,000 shares of class A common stock upon the conversion of 1,000,000 shares of series seed preferred stock. On July 17, 2023, the Company issued 940,000 shares of class B common stock upon the conversion of 940,000 shares of class A common stock. On July 24, 2023, the Company issued 370,000 shares of class B common stock upon the conversion of 370,000 shares of class A common stock. On February 5, 2024, the Company issued 750,000 shares of class A common stock upon the conversion of 750,000 shares of series seed preferred stock, which were immediately converted into 750,000 shares of class B common stock upon issuance. On February 6, 2024, the issued 200,000 shares of class B common stock upon the conversion of 200,000 shares of class A common stock. On February 7, 2024, the Company issued 1,250,000 shares of class A common stock upon the conversion of 1,250,000 shares of series seed preferred stock, which were immediately converted into 1,250,000 shares of class B common stock upon issuance. As of March 31, 2024, there were 150,000 shares of class A common stock and 5,305,940 shares of class B common stock issued and outstanding 2022 Equity Incentive Plan On September 16, 2022, the Company’s board of directors adopted the Company’s 2022 Equity Incentive Plan, which was adopted by stockholders on November 18, 2022, which reserved a total of 1,736,819 shares of the Company’s class B common stock for issuance. On January 3, 2024, the Company adopted an amendment to the , the total shares of class B common stock available for grant to 3,240,000. Additionally, the number of shares of class B common stock available for issuance under the 2022 Plan will automatically increase on January 1 of each calendar year during the term of the 2022 Plan by an amount equal to 5% of the total number of shares of class B common stock issued and outstanding on December 31 of the immediately preceding calendar year. Incentive awards authorized under the 2022 Plan include, but are not limited to, nonqualified stock options, incentive stock options, restricted stock awards, restricted stock units, performance grants intended to comply with Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), and stock appreciation rights. If an incentive award granted under the 2022 Plan expires, terminates, is unexercised for forfeited, the surrendered shares will become available for future awards under the 2022 Plan. The Company’s employees and advisors were awarded options under the 2022 Plan. Therefore, an allocation of the share-based compensation was made to the Company. Stock Options As of March 31, 2024, the Company has issued options to purchase an aggregate of 2,000,000 shares of class A common stock at an exercise price of $0.25 per share. In addition, the Company issued options to purchase 770,000 shares of class B common stock at a weighted average exercise price of $2.21 per share under the 2022 Plan. The class A options were fully vested as of the grant date and the class B options have a graded vesting term based on continuous service during the vesting period. Warrants On October 14, 2022 and November 29, 2022, the Company issued warrants for the purchase of 42,241 and 4,022 shares of class B common stock, respectively, to a third party as part of their compensation earned. The warrants were exercisable for a period of five years at an exercise price of $1.74 (subject to adjustments for stock dividends, stock splits, mergers, consolidations and similar transactions). On March 6, 2024, the Company cancelled these warrants without issuing a replacement award. As the warrants were already vested, previously recognized compensation cost was not reversed. On October 17, 2022, the Company issued a warrant for the purchase of 777,778 shares of class B common stock for an aggregate exercise price of $500,000 to Burlington. On November 29, 2022, Burlington exercised this warrant in full. Stock-based Compensation Stock options are granted at the fair market value of the underlying common stock on the date of recognizes the vesting period. The fair value of stock options was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions: Risk-free interest rate 3.71 % Dividend yield 0.0 % Expected volatility 53.05 % Expected life of awards 4.8 years The risk-free interest rate is based on U.S. government issues with a remaining term equal to the expected life of the awards. The determination of expected volatility is based on historical volatility of an appropriate industry sector index. The weighted average expected term was estimated for options using the average of the vesting term and contractual term of the awards. The weighted-average fair value of total awards granted during the period ended March 31, 2024 was $1.34. The information presented in the following table represents the awards granted and outstanding during the period: Warrants Stock Weighted Weighted Beginning balance - - - $ - Granted 824,041 - 0.44 0.69 Granted - 2,770,000 4.77 0.51 Cancelled - - - - Forfeited - - - - Exercised (777,778 ) - - 0.61 Outstanding, June 30, 2023 (2,125,152 shares exercisable) 46,263 2,770,000 5.01 $ 0.59 Granted - - - - Cancelled (46,263 ) - (0.24 ) (0.08 ) Forfeited - - - - Outstanding, March 31, 2024 ( 2,463,889 - 2,770,000 4.77 $ 0.51 The intrinsic value and total cash received of awards exercised for the period ending June 30, 2023 was $855,556 and $500,000, respectively. No cash awards were exercised during the nine-month period ended March 31, 2024. Total stock compensation expense recognized during the nine-month period ended March 31, 2024 consists of $151,978 related to stock options. In addition, $42,835 of warrants issued to underwriters were recorded as an offset to equity as of March 31, 2024. As of March 31, 2024, total unrecognized stock compensation expense was $187,973 with the weighted average period over which it is expected to be recognized of 3.25 years.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Mar. 31, 2024
Net Loss Per Share [Abstract]
Net loss per share	11. Net loss per share The following tables set forth the computation of basic and dilutive net loss per share of common stock: Three Months Ended March 31, 2024 2023 Basic and diluted net loss per share Class A Class B Class A Class B Numerator Allocation of undistributed loss $ (25,972 ) $ (494,698 ) $ (132,758 ) $ (190,999 ) Denominator Weighted average number of shares used in per share computation 231,319 4,405,940 1,000,000 1,438,699 Basic and diluted net loss per share $ (0.11 ) $ (0.11 ) $ (0.13 ) $ (0.13 ) Nine Months Ended March 31, 2024 Basic and diluted net loss per share Class A Class B Numerator Allocation of undistributed loss $ (117,376 ) $ (1,185,387 ) Denominator Weighted average number of shares used in per share computation 341,788 3,451,743 Basic and diluted net loss per share $ (0.34 ) $ (0.34 ) Period from October 17, Basic and diluted net loss per share Class A Class B Numerator Allocation of undistributed loss $ (2,030,183 ) $ (2,478,911 ) Denominator Weighted average number of shares used in per share computation 1,000,000 1,221,028 Basic and diluted net loss per share $ (2.03 ) $ (2.03 )

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Mar. 31, 2024
Commitments and Contingencies [Abstract]
Commitments and Contingencies	12. Commitments and Contingencies Legal Proceedings From time to time, the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. The Company is currently not aware of any such legal proceedings or claims that it believes will have a material adverse effect on its business, financial condition or operating results. Retirement Plans The Successor does not maintain a defined contribution plan or any other type of retirement plan for its employees. For the period July 1, 2022 through October 16, 2022, the Predecessor maintained a defined contribution 401(k) plan available to eligible employees. Employee contributions are voluntary and are determined on an individual basis, limited to the maximum amount allowable under federal tax regulations. Matching contributions to the 401(k) plan are made for certain eligible employees to meet the non- discrimination provisions of the plan. During this period, the Predecessor made a contribution of $1,512. Leases The Company has a non-cancellable operating lease commitment for its office facility expiring in 2028. Rent expense totaled $90,307 for the nine months ended March 31, 2024. The following table discloses the lease cost, discount rate, and remaining lease term for operating leases as of March 31, 2024: March 31, Operating lease cost $ 90,307 Remaining lease term 3.9 years Discount rate 6.56 % The discount rate was determined using the Company’s external debt and was adjusted for collateralization, term and lease amount. The following table discloses the undiscounted cash flows on an annual basis and a reconciliation of the undiscounted cash flows of operating lease liabilities recognized in the balance sheet as of March 31, 2024: Year Ending June 30, Amount 2024 (remainder) $ 40,450 2025 163,147 2026 167,226 2027 171,407 2028 116,160 Total undiscounted cash flows 658,390 Less amount representing interest (77,077 ) Present value of lease liabilities 581,313 Less current portion (128,749 ) Noncurrent lease liabilities $ 452,564

Subsequent Events

Subsequent Events	9 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	13. Subsequent Events The Company has evaluated events subsequent to March 31, 2024, to assess the need for potential recognition or disclosure. Such events were evaluated through June 10, 2024, the date these condensed financial statements were available to be issued. The following were noted: Initial Public Offering On April 25, 2024, the Company entered into an underwriting agreement with Boustead Securities, LLC, as the representative (the “Representative”) of the several underwriters named on Schedule 1 thereto (the “Underwriters”), relating to the Company’s initial public offering of class B common stock. Under the Underwriting Agreement, the Company agreed to sell 1,250,000 shares of class B common stock to the Underwriters, at a purchase price per share of $3.72 (the offering price to the public of $4.00 per share of class B common stock minus the Underwriters’ discount), and also agreed to grant to the Underwriters a 45-day option to purchase up to 187,500 additional shares of class B common stock, at a purchase price of $3.72, pursuant to the Company’s registration statement on Form S-1 (File No. 333-274928) under the Securities Act of 1933, as amended. On April 30, 2024, the closing of the initial public offering was completed. The Company sold 1,250,000 shares of class B common stock for total gross proceeds of $5,000,000. After deducting the underwriting commission and expenses, the Company received net proceeds of approximately $4,239,500. On April 30, 2024, pursuant to the Underwriting Agreement, the Company issued a class B common stock purchase warrant to the Representative for the purchase of 87,500 shares of class B common stock at an exercise price of $5.00, subject to adjustments. The warrant will be exercisable at any time and from time to time, in whole or in part, during the period commencing on April 30, 2024 and ending on April 25, 2029 and may be exercised on a cashless basis under certain circumstances. Stock Conversions On April 30, 2024, the Company issued 1,000,000 shares of class A common stock upon the conversion of 1,000,000 shares of series seed preferred stock. On May 15, 2024, the Company issued 880,000 shares of class B common stock upon the conversion of 880,000 shares of class A common stock. Conversion of Convertible Notes On May 2, 2024, the Company issued an aggregate of 257,479 shares of class B common stock upon the conversion of the 10% original issue discount convertible promissory notes issued on January 30, 2024 (see Note 8), which included principal of $250,000 and accrued interest of $7,479. Equity Awards On April 30, 2024, the Company granted a restricted stock award under the 2022 Plan for 100,000 shares of class B common stock, of which 15,000 shares vested on the date of grant, 21,250 shares will vest quarterly commencing on July 1, 2024 and the remaining 75,000 shares will vest upon the achievement of certain metrics. On April 30, 2024, the Company granted a restricted stock unit under the 2022 Plan for 1,300,000 shares of class B common stock, of which 87,500 shares vested and were issued on the date of grant, 37,500 shares will vest each quarter for seven quarters commencing on June 1, 2024, and the remaining shares will vest upon the achievement of certain metrics. On April 30, 2024, the Company granted options under the 2022 Plan to the Company’s three independent directors, each for the purchase of 150,000 shares of class B common stock at an exercise price of $4.00 per share, with 15,000 shares underlying each option vesting on the date of grant and the remaining shares vesting monthly commencing on May 25, 2024. On April 30, 2024, the Company granted an option under the 2022 Plan for the purchase of 75,000 shares of class B common stock at an exercise price of $4.00 per share, which vested in full on the date of grant. Debt Repayment On May 29, 2024, the Company repaid the two promissory notes issued on October 4, 2022 in full (see Note 9). Debt Extension and Amendment On April 30, 2024, the Company and Burlington entered into an extension agreement which extended the maturity date of the promissory note issued on October 17, 2022 (the “Original Note”) to May 9, 2024 (see Note 8). On May 31, 2024, Burlington and Walker Water LLC (“WW”) entered into an allonge, assignment and agreement (the “Assignment Agreement”), pursuant to which Burlington agreed to transfer $633,840.00 of the Original Note to WW. The Assignment Agreement also provided that the Company would make a payment of $900,000 on May 31, 2024 to Burlington to reduce the principal amount of the Original Note. In conjunction with the Assignment Agreement, the Company issued an amended and restated promissory note to Burlington (the “Amended Note”). The Amended Note has a new principal amount of $3,196,881, accrues interest at 8.5% per annum from October 17, 2022 (the date of the Original Note), which shall increase to 10% upon an event of default, and requires quarterly payments in the amount of $100,000 over the course of the next two and a half years, with a final payment of $1,396,881 due on April 1, 2027. The Amended Note may be prepaid at any time with no pre-payment penalty and contains customary events of default for a note of this type. Pursuant to the Assignment Agreement, the Company also issued a promissory note to WW in the principal amount of $633,840 (the “New Note”). The New Note accrues interest at 8.5% per annum from October 17, 2022 (the date of the Original Note), which shall increase to 10% upon an event of default, and is due on December 31, 2024. The New Note may be prepaid at any time with no pre-payment penalty and contains customary events of default for a note of this type.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended			9 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2024
Pay vs Performance Disclosure
Net Income (Loss)	$ (520,670)	$ (344,799)	$ (437,294)	$ (1,302,763)

Insider Trading Arrangements

Insider Trading Arrangements	Jul. 07, 2024
Douglas T Moore [Member]
Trading Arrangements, by Individual
Name	Douglas T. Moore
Title	Chairman, Chief Executive Officer and President
Clayton Adams [Member]
Trading Arrangements, by Individual
Name	Clayton Adams
Title	as Chairman, Chief Executive Officer and President.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying unaudited interim financial statements as of and for the three and nine-month periods ended March 31, 2024 and 2023 have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The interim financial statements are condensed and should be read in conjunction with the Company’s latest annual audited 2023 financial statements. The results of operations for interim periods are not necessarily indicative of results to be expected for the fiscal year ending June 30, 2024 or for any other future annual or interim period. The results of the Predecessor represent the combined financial statements of the accounts of CleanCore Solutions, LLC, TetraClean Systems, LLC and Food Safety Technologies, LLC. These combined financial statements include the accompanying combined statements of operations for the period ended July 1 to October 16, 2022, combined statement of members’ equity as of June 30, 2022 and October 16, 2022, and combined statement of cash flows for the period July 1, 2022 to October 16, 2022. All intercompany balances and transactions among the combined entities have been eliminated. In the opinion of predecessor management, all adjustments considered necessary for a fair presentation have been included.
Use of Estimates	Use of Estimates The preparation of the Company’s and Predecessor’s financial statements require management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure in the Company’s combined financial statements and accompanying notes. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management’s estimates. Significant estimates and assumptions made by the Company are allowance for bad debt, useful lives of fixed assets, warranty liabilities, and allowance for inventory obsolescence.
Risks and Uncertainties	Risks and Uncertainties The Company is subject to a number of risks similar to other early-stage companies including, but not limited to, profitability, the need for additional financing to achieve its business strategy, ability to obtain regulatory approval, significant competition, and dependence on key individuals.
Accounts Receivable	Accounts Receivable Accounts receivable is comprised of trade accounts receivables from the Company’s customers. Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company established an allowance for bad debt of accounts receivables based on a percentage assigned to aged days outstanding categories. The Predecessor established the allowance for bad debt based on various factors including credit profiles of the Company’s customers, historical payments, outstanding balances and current economic trends, and performed this analysis periodically. The Company recorded an allowance for doubtful accounts of $20,585 and $4,419 as of March 31, 2024 and June 30, 2023, respectively.
Inventory	Inventory Inventory consists of parts, work in progress and finished goods. The Company and its Predecessor value parts and finished goods at the lower of the actual costs or net realizable value. The Company and its Predecessor value work in progress at cost. The Company and Predecessor periodically review inventory for obsolete and potentially impaired items. As of March 31, 2024 and June 30, 2023, the Company had an allowance for inventory obsolescence of $19,235 and $14,940, respectively.
Leases	Leases The Company accounts for leases in accordance with Accounting Standards Codification (ASC) Topic 842 (Topic 842), Leases Lease payments include fixed and in-substance fixed payments, variable payments based on an index or rate, reasonably certain purchase options, termination penalties, and probable amounts the lessee will owe under a residual value guarantee. Variable lease payments are recognized as lease expenses as incurred, and generally relate to variable payments made based on the level of services provided by the landlords of our leases. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term within general and administrative expenses in the statement of operations. The Company uses its estimated incremental borrowing rate, which is derived from information available at the lease commencement date, in determining the present value of lease payments because the Company does not have the information necessary to determine the rate implicit in the lease. The Company’s lease term includes any option to extend the lease when it is reasonably certain to be exercised based on consideration of all relevant factors. Leases with an initial term of 12 months or less are not recorded on the balance sheets and the Company recognizes lease expense for these leases on a straight-line basis over the lease term.
Business Combinations	Business Combinations Business combinations are accounted for using the acquisition method. The fair value of total purchase consideration is allocated to the fair values of identifiable tangible and intangible assets acquired and liabilities assumed, with the remaining amount being classified as goodwill. All assets, liabilities and contingent liabilities acquired or assumed in a business combination are recorded at their fair values at the date of acquisition. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates, and selection of comparable companies. Estimates of fair value are based on assumptions believed to be reasonable, but are inherently uncertain and unpredictable and, as a result, actual results may differ from those estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill. At the conclusion of the measurement period, any subsequent adjustments are reflected in the statements of operations. Transaction costs associated with business combinations are expensed as incurred and are included in general and administrative expenses in the Company’s statements of operations.
Intangible Assets	Intangible Assets Intangible assets primarily consist of existing technology, customer relationships, and trademarks obtained as a result of the acquisition on October 17, 2022. Intangible assets with definite lives are amortized based on their pattern of economic benefit over their estimated useful lives and reviewed periodically for impairment. The Company’s trademarks are deemed to have an indefinite life. The estimated useful life of the acquired technology is 15 years while the estimated useful life of the customer relationships is 5 years.
Impairment of Goodwill	Impairment of Goodwill The Company evaluates goodwill for impairment annually, as of June 30, or more frequently when indicators of impairment exist. The Company considers qualitative factors including market conditions, legal factors, operating performance indicators, and competition, among others, to determine whether it is more likely than not that the fair value of the reporting unit is less than it’s carrying amount, including goodwill. If the Company concludes that it is more likely than not that the fair value of the reporting unit is less than it’s carrying amount, the Company performs a quantitative impairment test. In performing the quantitative impairment test, the Company compares the fair value of its reporting unit to the carrying amount including the goodwill of the reporting unit. If the carrying value, including goodwill, exceeds the reporting unit’s fair value, the Company will recognize an impairment loss for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company performed its first evaluation of goodwill on October 1, 2023. Based on the analysis, the Company did not recognize an impairment loss during the period ended March 31, 2024. Subsequent evaluations will be performed annually on June 30, per the Company’s policy.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets Long-lived assets consist primarily of property and equipment and intangible assets. Long-lived assets are tested for impairment when events and circumstances indicate the assets might be impaired by first comparing the estimated future undiscounted cash flows of the asset or asset group to the carrying value. If the carrying value exceeds the estimated future undiscounted cash flows, an impairment loss is recognized based on the amount that the carrying value exceeds the fair value of the asset or asset group. The Company did not recognize impairment losses during the periods ended March 31, 2024 and 2023.
Deferred Offering Costs	Deferred Offering Costs In accordance with ASC 340-10-S99-1 and SEC Accounting Bulletin Topic 5A, specific incremental costs incurred by the Company directly attributable to a proposed offering of securities have been deferred and will be charged against the gross proceeds of the offering. These offering costs include fees paid to underwriters, attorney, accountants as well as printers and other third parties directly related to the offering. Costs such as management salaries or other general administrative expenses that are not incremental to the offering are not included in the deferred costs. As of March 31, 2024 and June 30, 2023, the Company had $773,749 and $302,755, respectively, of deferred offering costs.
Patent Costs	Patent Costs Costs related to filing and pursuing patent applications are expensed as incurred, as recoverability of such expenditures is uncertain. These costs are included in general and administrative expenses.
Advertising Costs	Advertising Costs The Company reports as expense the cost of advertising and promoting its services as incurred. Such amounts are totaled $17,737 and $2,210 for the three-month periods ended March 31, 2024 and 2023, respectively, and $43,191 (successor), $12,814 (successor) and $4,621 (predecessor), for a total of $17,435, for the nine month periods ended March 31, 2024 and 2023, respectively.
Stock-based Compensation	Stock-based Compensation Compensation expense is recognized for all share-based payments to employees and non-employees, including stock options and warrants, in the statements of operation based on the fair value of the awards that are granted. The Company’s stock price at the date of grant was estimated using an acceptable valuation technique such as the probability-weighted expected return model. The fair value of stock options is estimated at the date of grant using the Black-Scholes option-pricing model. Generally, measured compensation cost, net of actual forfeitures, is recognized on a straight-line basis over the vesting period of the related share-based compensation award. The Company accounts for forfeitures of stock-based awards as they occur.
Revenue Recognition	Revenue Recognition The Company generates revenues from sales of its products and recognizes revenue as control of its products is transferred to its customers, which is generally at the time of shipment based on the contractual terms with the Company’s customers. The Company provides customer programs and incentive offerings, including growth incentives and volume-based incentives. These customer programs and incentives are considered variable consideration. The Company includes in revenue variable consideration only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the variable consideration is resolved. This determination is made based upon known customer program and incentive offerings at the time of sale, and expected sales volume forecasts as it relates to the Company’s volume-based incentives. This determination is updated every reporting period. For the periods ended March 31, 2024 and 2023, customer growth and volume-based incentives were minimal. Certain product sales include a 2-year manufacturer’s warranty that provides the customer with assurance that the product performs as intended. Such warranties are assurance-type warranties and are accounted for as contingencies under ASC 460-10. Refer to Note 7 for warranty reserve.
Net Loss per Share of Common Stock	Net Loss per Share of Common Stock Basic net loss per class A and class B common share is calculated by dividing the net loss distributed to class A and class B, respectively, by the weighted-average number of common shares of each respective class outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, stock options, warrants, and convertible debt are considered to be potentially dilutive securities. As of March 31, 2024 and 2023, there were potential common stock equivalents excluded from the diluted loss per share calculations as their effect is anti-dilutive
New Accounting Pronouncements	New Accounting Pronouncements No recent accounting pronouncement or changes in accounting pronouncements have been issued or adopted that are of material significance, or have potential material significance, to the Company’s financial statements since those discussed in the Company’s fiscal year 2023 audited financial statements.

Disaggregated Revenue (Tables)

Disaggregated Revenue (Tables)	9 Months Ended
	Mar. 31, 2024
Disaggregated Revenue [Abstract]
Schedule of Disaggregates Revenue	The following table disaggregates revenue by product category for the following periods ended: Three Months Ended 2024 2023 Janitorial and Sanitation $ 258,819 $ 583,805 Ice System 6,549 9,601 Commercial and Residential Laundry 6,991 3,004 Other 41,561 24,996 Total revenue $ 313,920 $ 621,406 Nine Months Ended Nine March 31, (Successor) October 17, July 1, Janitorial and Sanitation $ 722,206 $ 1,430,570 $ 369,089 Ice System 10,133 16,059 16,744 Commercial and Residential Laundry 9,060 3,004 6,444 Other 156,611 20,542 110,713 Total revenue $ 898,010 $ 1,470,175 $ 502,990

Accounts Receivable, Net (Table

Accounts Receivable, Net (Tables)	9 Months Ended
	Mar. 31, 2024
Accounts Receivable, Net [Abstract]
Schedule of Accounts Receivable, Net	Accounts receivable, net consists of the following at: March 31, June 30, Trade accounts receivable $ 316,639 $ 237,979 Allowance for doubtful accounts (20,585 ) (4,419 ) Total accounts receivable, net $ 296,054 $ 233,560

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Mar. 31, 2024
Inventory [Abstract]
Schedule of Inventory	Inventory consists of the following at: March 31, June 30, Parts $ 525,093 $ 551,264 Finished goods 269,827 135,792 Inventory reserve (19,235 ) (14,940 ) Total inventory, net $ 775,685 $ 672,116

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	9 Months Ended
	Mar. 31, 2024
Accounts Payable and Accrued Expenses [Abstract]
Schedule of Accounts Payable and Accrued Expenses	Accounts payable and accrued expenses consist of the following at: March 31, June 30, Accounts payable $ 722,734 $ 266,511 Accrued interest 376,467 152,684 Accrued payroll and related expenses 313,910 68,026 Warranty reserve 112,559 156,333 Other accrued expenses 75,554 1,073 Total accounts payable and other accrued expenses $ 1,601,224 $ 644,627

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Schedule of Due from Related Party Balances	The following due to related party balances were outstanding at: March 31, June 30, Due to founder – credit card $ 62,416 $ 12,402 Due to founders 208,900 208,900 Total due to related parties $ 271,316 $ 221,302

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Mar. 31, 2024
Stockholders’ Equity [Abstract]
Schedule of Fair Value of Stock Options was Estimated at the Date of Grant Using a Black-Scholes Option-Pricing Model	The fair value of stock options was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions: Risk-free interest rate 3.71 % Dividend yield 0.0 % Expected volatility 53.05 % Expected life of awards 4.8 years
Schedule of Information Presented In the Following Table Represents the Awards Granted and Outstanding During the Period	The information presented in the following table represents the awards granted and outstanding during the period: Warrants Stock Weighted Weighted Beginning balance - - - $ - Granted 824,041 - 0.44 0.69 Granted - 2,770,000 4.77 0.51 Cancelled - - - - Forfeited - - - - Exercised (777,778 ) - - 0.61 Outstanding, June 30, 2023 (2,125,152 shares exercisable) 46,263 2,770,000 5.01 $ 0.59 Granted - - - - Cancelled (46,263 ) - (0.24 ) (0.08 ) Forfeited - - - - Outstanding, March 31, 2024 ( 2,463,889 - 2,770,000 4.77 $ 0.51

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Mar. 31, 2024
Net Loss Per Share [Abstract]
Schedule of Basic and Dilutive Net Loss Per Share of Common Stock	The following tables set forth the computation of basic and dilutive net loss per share of common stock: Three Months Ended March 31, 2024 2023 Basic and diluted net loss per share Class A Class B Class A Class B Numerator Allocation of undistributed loss $ (25,972 ) $ (494,698 ) $ (132,758 ) $ (190,999 ) Denominator Weighted average number of shares used in per share computation 231,319 4,405,940 1,000,000 1,438,699 Basic and diluted net loss per share $ (0.11 ) $ (0.11 ) $ (0.13 ) $ (0.13 ) Nine Months Ended March 31, 2024 Basic and diluted net loss per share Class A Class B Numerator Allocation of undistributed loss $ (117,376 ) $ (1,185,387 ) Denominator Weighted average number of shares used in per share computation 341,788 3,451,743 Basic and diluted net loss per share $ (0.34 ) $ (0.34 ) Period from October 17, Basic and diluted net loss per share Class A Class B Numerator Allocation of undistributed loss $ (2,030,183 ) $ (2,478,911 ) Denominator Weighted average number of shares used in per share computation 1,000,000 1,221,028 Basic and diluted net loss per share $ (2.03 ) $ (2.03 )

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Mar. 31, 2024
Commitments and Contingencies [Abstract]
Schedule of Lease Cost, Discount Rate, and Remaining Lease Term for Operating Leases	The following table discloses the lease cost, discount rate, and remaining lease term for operating leases as of March 31, 2024: March 31, Operating lease cost $ 90,307 Remaining lease term 3.9 years Discount rate 6.56 %
Schedule of Undiscounted Cash Flows	The following table discloses the undiscounted cash flows on an annual basis and a reconciliation of the undiscounted cash flows of operating lease liabilities recognized in the balance sheet as of March 31, 2024: Year Ending June 30, Amount 2024 (remainder) $ 40,450 2025 163,147 2026 167,226 2027 171,407 2028 116,160 Total undiscounted cash flows 658,390 Less amount representing interest (77,077 ) Present value of lease liabilities 581,313 Less current portion (128,749 ) Noncurrent lease liabilities $ 452,564

Organization and Business (Deta

Organization and Business (Details) - USD ($)		3 Months Ended			9 Months Ended
	Apr. 25, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2024	Apr. 01, 2023	Nov. 29, 2022	Oct. 14, 2022
Organization and Business (Details) [Line Items]
Cash		$ 56,082			$ 56,082
Net loss		$ (520,670)	$ (344,799)	$ (437,294)	(1,302,763)
Cash used for operating activities					(485,530)
Purchase price per share (in Dollars per share)	$ 3.72
Offering price (in Dollars per share)	$ 4					$ 1.74
Underwriters discount percentage	7%
Additional shares (in Shares)	187,500
Purchase price (in Dollars per share)	$ 3.72
Received net proceeds					$ 4,239,500
Class B Common Stock [Member]
Organization and Business (Details) [Line Items]
Sale of stock (in Shares)	1,250,000
Purchase price (in Dollars per share)							$ 1.74	$ 1.74
Sold shares (in Shares)		1,250,000			1,250,000
Total gross proceeds					$ 5,000,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023
Summary of Significant Accounting Policies (Details) [Line Items]
Allowance for doubtful accounts	$ 20,585		$ 20,585		$ 4,419
Allowance for inventory obsolescence	19,235		19,235		14,940
Deferred offering cost	773,749		773,749		$ 302,755
Advertising cost	$ 17,737		43,191	$ 4,621
Promoting expenses		$ 2,210	12,814
Total adverstising costs			$ 17,435	$ 17,435
Acquired Technology [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Estimated useful life	15 years		15 years
Customer Relationships [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Estimated useful life	5 years		5 years
Class A Common Stock [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Anti dilutive share (in Shares)			2,770,000	2,770,000

Disaggregated Revenue (Details)

Disaggregated Revenue (Details) - Schedule of Disaggregates Revenue - USD ($)	3 Months Ended		4 Months Ended	5 Months Ended	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Oct. 16, 2022	Mar. 31, 2023	Mar. 31, 2024
Schedule of Disaggregates Revenue [Line Items]
Total revenue	$ 313,920	$ 621,406	$ 502,990	$ 1,470,175	$ 898,010
Janitorial and Sanitation [Member]
Schedule of Disaggregates Revenue [Line Items]
Total revenue	258,819	583,805	369,089	1,430,570	722,206
Ice System [Member]
Schedule of Disaggregates Revenue [Line Items]
Total revenue	6,549	9,601	16,744	16,059	10,133
Commercial and Residential Laundry [Member]
Schedule of Disaggregates Revenue [Line Items]
Total revenue	6,991	3,004	6,444	3,004	9,060
Other [Member]
Schedule of Disaggregates Revenue [Line Items]
Total revenue	$ 41,561	$ 24,996	$ 110,713	$ 20,542	$ 156,611

Accounts Receivable, Net (Detai

Accounts Receivable, Net (Details) - Schedule of Accounts Receivable, Net - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Schedule of Accounts Receivable, Net [Abstract]
Trade accounts receivable	$ 316,639	$ 237,979
Allowance for doubtful accounts	(20,585)	(4,419)
Total accounts receivable, net	$ 296,054	$ 233,560

Inventory (Details)

Inventory (Details) - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Inventory [Abstract]
Adjusted the inventory reserve	$ 19,235	$ 14,940

Inventory (Details) - Schedule

Inventory (Details) - Schedule of Inventory - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Schedule of Inventory [Abstract]
Parts	$ 525,093	$ 551,264
Finished goods	269,827	135,792
Inventory reserve	(19,235)	(14,940)
Total inventory, net	$ 775,685	$ 672,116

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - Schedule of Accounts Payable and Accrued Expenses - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Schedule of Accounts Payable and Accrued Expenses [Abstract]
Accounts payable	$ 722,734	$ 266,511
Accrued interest	376,467	152,684
Accrued payroll and related expenses	313,910	68,026
Warranty reserve	112,559	156,333
Other accrued expenses	75,554	1,073
Total accounts payable and other accrued expenses	$ 1,601,224	$ 644,627

Debt (Details)

Debt (Details) - USD ($)		9 Months Ended
	Jan. 30, 2024	Mar. 31, 2024	Oct. 17, 2023	Sep. 13, 2023	Oct. 17, 2022
Debt [Line Items]
Principal amount					$ 3,000,000
Accrued amount		$ 355,726
Convertible Promissory Notes [Member]
Debt [Line Items]
Interest rate			7%	10%
Original issue discount percentage	10%
Principal amount percentage	12%
Accrued interest amount		$ 4,545
Separate Accredited Investors [Member]
Debt [Line Items]
Principal amount	$ 27,778
Purchase price	25,000
Separate Accredited Investors One [Member]
Debt [Line Items]
Principal amount	111,111
Purchase price	100,000
Separate Accredited Investors Two [Member]
Debt [Line Items]
Principal amount	111,111
Purchase price	$ 100,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		1 Months Ended	9 Months Ended
	Oct. 04, 2022	Mar. 26, 2024	Mar. 31, 2024	Jun. 30, 2023
Related Party Transactions (Details) [Line Items]
Short term amount due for operational expenses			$ 271,316	$ 221,302
Principal amount	$ 104,450	$ 500,000
Investment Interest Rate		8%
Debt Instrument, Interest Rate, Increase (Decrease)		13%
Matthew Atkinson [Member]
Related Party Transactions (Details) [Line Items]
Accrued interest			15,567
Clayton Adams [Member]
Related Party Transactions (Details) [Line Items]
Short term amount due for operational expenses			62,416
Principal amount			$ 0
Matthew Atkinson [Member]
Related Party Transactions (Details) [Line Items]
Short term amount due for operational expenses	$ 208,900
Chief Executive Officer [Member]
Related Party Transactions (Details) [Line Items]
Bear interest rate	5%

Related Party Transactions (D_2

Related Party Transactions (Details) - Schedule of Due from Related Party Balances - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Related Party Transaction [Line Items]
Total due to related parties	$ 271,316	$ 221,302
Founder – Credit Card [Member]
Related Party Transaction [Line Items]
Total due to related parties	62,416	12,402
Founders [Member]
Related Party Transaction [Line Items]
Total due to related parties	$ 208,900	$ 208,900

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)											3 Months Ended		6 Months Ended	9 Months Ended
	Feb. 07, 2024	Feb. 06, 2024	Feb. 05, 2024	Jul. 24, 2023	Jul. 17, 2023	Jul. 16, 2023	Jun. 30, 2023	Jun. 01, 2023	Apr. 01, 2023	Sep. 16, 2022	Mar. 31, 2024	Sep. 30, 2023	Dec. 31, 2023	Mar. 31, 2024	Apr. 25, 2024	Nov. 29, 2022	Oct. 17, 2022	Oct. 14, 2022	Sep. 30, 2022	Aug. 26, 2022
Stockholders' Equity [Line Items]
Preferred Stock authorized							4,000,000				4,000,000			4,000,000
Preferred Stock, par value (in Dollars per share)							$ 0.0001				$ 0.0001			$ 0.0001
Voting rights														one
Conversion price (in Dollars per share)											$ 0.25			$ 0.25
Preferred stock, shares issued							4,000,000				1,000,000			1,000,000
Purchase price per share (in Dollars per share)															$ 3.72
Preferred stock, shares outstanding							4,000,000				1,000,000			1,000,000
Aggregate exercise price (in Dollars)																	$ 500,000
Purchase price per share (in Dollars per share)									$ 1.74						$ 4
Total stock compensation expense (in Dollars)									$ 29,999
Shares available for grant										3,240,000
Warrants exercise price (in Dollars per share)													$ 1.74
Weighted-average fair value of total awards granted (in Dollars per share)														$ 1.34
Intrinsic value (in Dollars)							$ 855,556
Total cash received of awards exercised (in Dollars)							$ 500,000
Total unrecognized stock compensation expense (in Dollars)											$ 187,973			$ 187,973
Expected term														4 years 9 months 18 days
Warrant [Member]
Stockholders' Equity [Line Items]
Percentage of total number of shares of common stock issued and outstanding													5%
Warrants issued (in Dollars)											$ 42,835			$ 42,835
Expected term														3 years 3 months
Stock Options [Member]
Stockholders' Equity [Line Items]
Total stock compensation expense (in Dollars)														$ 151,978
Class A Common Stock [Member]
Stockholders' Equity [Line Items]
Common stock authorized							50,000,000				50,000,000			50,000,000
Common stock, shares issued							660,000				150,000			150,000
Common stock, par value (in Dollars per share)							$ 0.0001				$ 0.0001			$ 0.0001
Purchase price per share (in Dollars per share)																				$ 0.0001
Conversion of shares								340,000
Common stock, shares outstanding							660,000				150,000			150,000
Exercise price (in Dollars per share)													$ 0.25
Class A Common Stock [Member] | Stock Options [Member]
Stockholders' Equity [Line Items]
Purchase of shares													2,000,000
Class A Common Stock [Member] | Conversion Rights [Member]
Stockholders' Equity [Line Items]
Conversion of shares	1,250,000
Class A Common Stock [Member] | Convertion Shares [Member]
Stockholders' Equity [Line Items]
Conversion of shares		200,000		370,000	940,000
Class B Common Stock [Member]
Stockholders' Equity [Line Items]
Common stock authorized							250,000,000				250,000,000			250,000,000
Common stock, shares issued							1,795,940				5,305,940			5,305,940
Common stock, par value (in Dollars per share)							$ 0.0001				$ 0.0001			$ 0.0001
Purchase price per share (in Dollars per share)																$ 1.74		$ 1.74
Conversion of shares	1,250,000		750,000
Aggregate shares																		603,450
Conversion of shares								340,000
Common stock, shares outstanding							1,795,940				5,305,940			5,305,940
Shares reserved										1,736,819
Weighted average exercise price (in Dollars per share)													$ 2.21
Class B Common Stock [Member] | Warrant [Member]
Stockholders' Equity [Line Items]
Common stock, shares issued																777,778
Aggregate exercise price (in Dollars)																$ 500,000
Purchase of shares																4,022	777,778	42,241
Class B Common Stock [Member] | Stock Options [Member]
Stockholders' Equity [Line Items]
Purchase of shares													770,000
Class B Common Stock [Member] | Convertion Shares [Member]
Stockholders' Equity [Line Items]
Common stock, shares issued		200,000		370,000	940,000				17,241							57,471
Series Seed Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock authorized											4,000,000			4,000,000
Preferred stock, shares issued										2,000,000									2,000,000
Purchase price per share (in Dollars per share)										$ 0.25									$ 0.25
Conversion of shares	1,250,000		750,000
Series Seed Preferred Stock [Member] | Conversion Rights [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares issued											1,000,000			1,000,000
Preferred stock, shares outstanding											1,000,000			1,000,000
Preferred Stock [Member] | Conversion Rights [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares issued	1,250,000
Liquidation Rights [Member]
Stockholders' Equity [Line Items]
Dividends per share (in Dollars per share)											$ 0.25			$ 0.25
Liquidation Rights [Member] | Class A Common Stock [Member]
Stockholders' Equity [Line Items]
Dividends per share (in Dollars per share)											$ 0.25			$ 0.25
Common Stock [Member]
Stockholders' Equity [Line Items]
Common stock authorized											350,000,000			350,000,000
Common stock, shares issued											300,000,000			300,000,000
Common Stock [Member] | Class A Common Stock [Member]
Stockholders' Equity [Line Items]
Common stock, shares issued	1,250,000		750,000			1,000,000														1,000,000
Conversion of shares						1,000,000
Conversion of shares											(2,200,000)	(1,310,000)
Common Stock [Member] | Class B Common Stock [Member]
Stockholders' Equity [Line Items]
Conversion of shares											2,200,000	1,310,000
Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock authorized											50,000,000			50,000,000
Preferred Stock [Member] | Class A Common Stock [Member]
Stockholders' Equity [Line Items]
Conversion of shares			750,000
Preferred Stock [Member] | Series Seed Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares issued			750,000			1,000,000
Conversion of shares						1,000,000

Stockholders' Equity (Details)

Stockholders' Equity (Details) - Schedule of Fair Value of Stock Options was Estimated at the Date of Grant Using a Black-Scholes Option-Pricing Model	9 Months Ended
	Mar. 31, 2024
Schedule of Fair Value of Stock Options was Estimated at the Date of Grant Using a Black-Scholes Option-Pricing Model [Abstract]
Risk-free interest rate	3.71%
Dividend yield	0%
Expected volatility	53.05%
Expected life of awards	4 years 9 months 18 days

Stockholders' Equity (Details_2

Stockholders' Equity (Details) - Schedule of Information Presented In the Following Table Represents the Awards Granted and Outstanding During the Period - $ / shares	9 Months Ended	12 Months Ended
	Mar. 31, 2024	Jun. 30, 2023
Schedule of Information Presented In the Following Table Represents the Awards Granted and Outstanding During the Period [Abstract]
Warrants, Beginning balance	46,263
Stock Options, Beginning balance	2,770,000
Weighted Average Remaining Life (years), Beginning balance
Weighted Average Exercise Price, Beginning balance (in Dollars per share)	$ 0.59
Warrants,Granted		824,041
Weighted Average Remaining Life (years),Granted		5 months 8 days
Weighted Average Exercise Price, Granted (in Dollars per share)		$ 0.69
Warrants,Granted
Stock Options, Granted		2,770,000
Weighted Average Remaining Life (years),Granted		4 years 9 months 7 days
Weighted Average Exercise Price, Granted (in Dollars per share)		$ 0.51
Warrants, Cancelled	(46,263)
Weighted Average Remaining Life (years),Canceled	2 months 26 days
Weighted Average Exercise Price, Cancelled (in Dollars per share)	$ (0.08)
Warrants, Forfeited
Stock Options, Forfeited
Warrants, Exercised		(777,778)
Weighted Average Exercise PriceExercised (in Dollars per share)		$ 0.61
Warrants,ending balance		46,263
Stock Options, Outstanding,	2,770,000	2,770,000
Weighted Average Remaining Life (years),Outstanding,	4 years 9 months 7 days	5 years 3 days
Weighted Average Exercise Price Outstanding, (in Dollars per share)	$ 0.51	$ 0.59

Stockholders' Equity (Details_3

Stockholders' Equity (Details) - Schedule of Information Presented In the Following Table Represents the Awards Granted and Outstanding During the Period (Parentheticals) - shares	9 Months Ended	12 Months Ended
	Mar. 31, 2024	Jun. 30, 2023
Schedule of Information Presented In the Following Table Represents the Awards Granted and Outstanding During the Period [Abstract]
Warrants, Outstanding, shares exercisable	2,463,889	2,125,152

Net Loss Per Share (Details) -

Net Loss Per Share (Details) - Schedule of Basic and Dilutive Net Loss Per Share of Common Stock - USD ($)	3 Months Ended		5 Months Ended	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2023	Mar. 31, 2024
Class A [Member]
Numerator
Allocation of undistributed loss	$ (25,972)	$ (132,758)	$ (2,030,183)	$ (117,376)
Denominator
Weighted average number of shares used in per share computation	231,319	1,000,000	1,000,000	341,788
Basic net loss per share	$ (0.11)	$ (0.13)	$ (2.03)	$ (0.34)
Class B [Member]
Numerator
Allocation of undistributed loss	$ (494,698)	$ (190,999)	$ (2,478,911)	$ (1,185,387)
Denominator
Weighted average number of shares used in per share computation	4,405,940	1,438,699	1,221,028	3,451,743
Basic net loss per share	$ (0.11)	$ (0.13)	$ (2.03)	$ (0.34)

Net Loss Per Share (Details) _2

Net Loss Per Share (Details) - Schedule of Basic and Dilutive Net Loss Per Share of Common Stock (Parentheticals) - $ / shares	3 Months Ended		5 Months Ended	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2023	Mar. 31, 2024
Class A [Member]
Schedule of Basic and Dilutive Net Loss Per Share of Common Stock [Line Items]
Diluted net loss per share	$ (0.11)	$ (0.13)	$ (2.03)	$ (0.34)
Class B [Member]
Schedule of Basic and Dilutive Net Loss Per Share of Common Stock [Line Items]
Diluted net loss per share	$ (0.11)	$ (0.13)	$ (2.03)	$ (0.34)

Commitments and Contingencies_2

Commitments and Contingencies (Details)	9 Months Ended
	Mar. 31, 2024 USD ($)
Commitments and Contingencies [Abstract]
Predecessor contribution	$ 1,512
Rent expense	$ 90,307

Commitments and Contingencies_3

Commitments and Contingencies (Details) - Schedule of Lease Cost, Discount Rate, and Remaining Lease Term for Operating Leases	9 Months Ended
	Mar. 31, 2024 USD ($)
Schedule of Lease Cost, Discount Rate, and Remaining Lease Term for Operating Leases [Abstract]
Operating lease cost	$ 90,307
Remaining lease term	3 years 10 months 24 days
Discount rate	6.56%

Commitments and Contingencies_4

Commitments and Contingencies (Details) - Schedule of Undiscounted Cash Flows - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Schedule of Undiscounted Cash Flows [Abstract]
2024 (remainder)	$ 40,450
2025	163,147
2026	167,226
2027	171,407
2028	116,160
Total undiscounted cash flows	658,390
Less amount representing interest	(77,077)
Present value of lease liabilities	581,313
Less current portion	(128,749)	$ (87,985)
Noncurrent lease liabilities	$ 452,564	$ 398,540

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)

12 Months Ended

Apr. 01, 2027

Jul. 01, 2024

May 15, 2024

May 02, 2024

Apr. 30, 2024

Apr. 25, 2024

Jun. 01, 2023

Oct. 17, 2022

Jun. 30, 2023

May 31, 2024

Mar. 31, 2024

Dec. 31, 2023

Nov. 29, 2022

Oct. 14, 2022

Aug. 26, 2022

Subsequent Events [Line Items]

Purchase price per share (in Dollars per share)

$ 3.72

Additional shares

187,500

Warrant exercise price (in Dollars per share)

$ 1.74

Issued the date of grant

2,770,000

Burlington [Member]

Subsequent Events [Line Items]

Principal amount (in Dollars)

$ 3,196,881

Accrued interest

8.50%

Rate shall increase percentage

10%

Payments amount (in Dollars)

$ 100,000

Walker Water LLC [Member]

Subsequent Events [Line Items]

Principal amount (in Dollars)

$ 633,840

Accrued interest

8.50%

Rate shall increase percentage

10%

Subsequent Event [Member]

Subsequent Events [Line Items]

Restricted stock award (in Dollars)

$ 1,300,000

Shares vested

87,500

Subsequent Event [Member] | Conversion of Convertible Notes [Member]

Subsequent Events [Line Items]

Convertible promissory notes issued (in Dollars)

$ 250,000

Accrued interest (in Dollars)

$ 7,479

Subsequent Event [Member] | Series Seed Preferred Stock [Member]

Subsequent Events [Line Items]

Conversion of stock

1,000,000

Subsequent Event [Member] | Equity Awards [Member]

Subsequent Events [Line Items]

Restricted stock award (in Dollars)

$ 100,000

Subsequent Event [Member] | 2022 Plan [Member]

Subsequent Events [Line Items]

Shares vested

15,000

Issued the date of grant

21,250

Subsequent Event [Member] | Restricted Stock [Member]

Subsequent Events [Line Items]

Issued the date of grant

37,500

Class B Common Stock [Member]

Subsequent Events [Line Items]

Sale of common stock

1,250,000

Purchase price per share (in Dollars per share)

$ 1.74

$ 1.74

Common stock, shares issued

1,795,940

5,305,940

Conversion of stock

340,000

Class B Common Stock [Member] | Subsequent Event [Member]

Subsequent Events [Line Items]

Purchase price per share (in Dollars per share)

$ 3.72

Additional shares

187,500

Class B Common Stock [Member] | Subsequent Event [Member] | Conversion of Convertible Notes [Member]

Subsequent Events [Line Items]

Conversion of convertible note shares

257,479

Conversion percentage

10%

Class B Common Stock [Member] | Subsequent Event [Member] | Warrant [Member]

Subsequent Events [Line Items]

Purchase warrants (in Dollars)

$ 87,500

Warrant exercise price (in Dollars per share)

$ 5

Class B Common Stock [Member] | Subsequent Event [Member] | Equity Awards [Member]

Subsequent Events [Line Items]

Issued the date of grant

15,000

Purchase of shares

150,000

Exercise price per share (in Dollars per share)

$ 4

Class B Common Stock [Member] | Subsequent Event [Member] | 2022 Plan [Member]

Subsequent Events [Line Items]

Purchase of shares

75,000

Exercise price per share (in Dollars per share)

$ 4

Class A Common Stock [Member]

Subsequent Events [Line Items]

Purchase price per share (in Dollars per share)

$ 0.0001

Common stock, shares issued

660,000

150,000

Conversion of stock

340,000

Class A Common Stock [Member] | Subsequent Event [Member]

Subsequent Events [Line Items]

Common stock, shares issued

1,000,000

Forecast [Member]

Subsequent Events [Line Items]

Principal amount (in Dollars)

$ 900,000

Forecast [Member] | 2022 Plan [Member]

Subsequent Events [Line Items]

Issued the date of grant

75,000

Forecast [Member] | Assignment Agreement [Member]

Subsequent Events [Line Items]

Transfer of agreed amount (in Dollars)

$ 633,840

Forecast [Member] | Burlington [Member]

Subsequent Events [Line Items]

Payments (in Dollars)

$ 1,396,881

Forecast [Member] | Class B Common Stock [Member]

Subsequent Events [Line Items]

Common stock, shares issued

880,000

Forecast [Member] | Class A Common Stock [Member]

Subsequent Events [Line Items]

Conversion of stock

880,000

Initial Public Offering [Member] | Class B Common Stock [Member] | Subsequent Event [Member]

Subsequent Events [Line Items]

Sale of common stock

1,250,000

1,250,000

Purchase price per share (in Dollars per share)

$ 3.72

Offering price per share (in Dollars per share)

$ 4

Gross proceeds (in Dollars)

$ 5,000,000

Net proceeds from issuance of initial public offering (in Dollars)

$ 4,239,500